Mark Kelley

Author PubWeight™ 11.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference.	Crit Care Med	2007	2.42
2	The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression.	Proc Natl Acad Sci U S A	2002	1.52
3	A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response.	Magn Reson Imaging	2009	1.23
4	t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism.	Cancer Res	2008	1.15
5	Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.	J Magn Reson Imaging	2009	1.06
6	Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms.	Med Phys	2010	0.93
7	The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells.	J Biol Chem	2008	0.91
8	Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin.	Stem Cells	2004	0.91
9	Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study.	Breast Cancer Res Treat	2011	0.88
10	Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation.	Exp Clin Transplant	2005	0.76
11	Meet Mark Kelley, MD, CEO of the Henry Ford Medical Group. Interviews by Paul Natinsky.	Mich Med	2009	0.75